AVXL
NASDAQ · Biotechnology
Anavex Life Sciences Corp
$2.89
-1.30 (-31.03%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+932.9% upside
Low Target
$17.55
Average Target
$29.85
High Target
$40.51
Current Price
$2.89
Current
$2.89
$2.89
Target
$29.85
$29.85
$17.55
$29.85 avg
$40.51
Scenario Analysis
Bear Case
$17.55
507.3%
Low target
Base Case
$29.85
+932.9%
Avg target
Bull Case
$40.51
+1,301.7%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$13.99
-79.3% from high
52-Week Low
$2.86
+1.0% from low
Target vs 52W High
$29.85
+113.4% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |